Steven E. Shoelson, MD, PhD

Affiliations: 
Joslin Diabetes Center  Harvard University, Cambridge, MA, United States 
Area:
insulin resistance and type 2 diabetes. Structural biology of diabetes and insulin resistance.
Website:
http://www.joslinresearch.org/pinet/InvestigatorDetail.asp?InvestigatorID=24
Google:
"Steven E. Shoelson"
Bio:

http://www.fas.harvard.edu/~biophys/Steven_E_Shoelson.htm

Mean distance: 20.96 (cluster 59)
 
SNBCP
Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Arthur H. Rubenstein grad student 1984 Chicago (Chemistry Tree)
Howard S. Tager grad student 1984 Chicago (Chemistry Tree)
 (Design, synthesis, and characteristics of peptide models of enzyme inhibitors)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee BC, Kim MS, Pae M, et al. (2016) Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity. Cell Metabolism
Rubin MR, Goldfine AB, McMahon DJ, et al. (2015) Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine
Pearce LR, Joe R, Doche ME, et al. (2014) Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1. Endocrinology. 155: 3219-26
Okazaki T, Liang F, Li T, et al. (2014) Muscle-specific inhibition of the classical nuclear factor-κB pathway is protective against diaphragmatic weakness in murine endotoxemia. Critical Care Medicine. 42: e501-9
Lee J, Miyazaki M, Romeo GR, et al. (2014) Insulin receptor activation with transmembrane domain ligands. The Journal of Biological Chemistry. 289: 19769-77
Goldfine AB, Jablonski KA, Shoelson SE, et al. (2014) Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139. Diabetes Care. 37: e112
Barzilay JI, Jablonski KA, Fonseca V, et al. (2014) The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes Care. 37: 1083-91
Kim MS, Yamamoto Y, Kim K, et al. (2013) Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. Plos One. 8: e82847
King AJ, Guo Y, Cai D, et al. (2013) Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes. Plos One. 8: e77452
Goldfine AB, Buck JS, Desouza C, et al. (2013) Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes Care. 36: 4132-9
See more...